TRYNGOLZA DIN 02563886
Health Canada record
| Active ingredient(s) | OLEZARSEN (OLEZARSEN SODIUM) 80 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AX OTHER LIPID MODIFYING AGENTS |
| Original market date | 04-Feb-2026 |
| Current status date | 20-Jul-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37961 | 2026-07-20 | New Drug Submission (NDS) | Administrative: Change in product ownership |
| 36553 | 2025-12-16 | New Drug Submission (NDS) |